Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial [Phase 3]
This Phase III trial update evaluates a biweekly regimen of eribulin versus a standard regimen for locally recurrent or metastatic HER2-nega…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial. [NA]
This clinical trial investigates whether axillary clearance can be omitted after macrometastases detected in sentinel node biopsy for breast…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. [NA]
Clinical trial update describes evaluating Disitamab Vedotin with metronomic chemotherapy for advanced HER2-positive breast cancer; current …
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer [NA]
This clinical trial is evaluating sirolimus albumin-bound in combination with palbociclib and fulvestrant for advanced HR-positive, HER2-neg…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia [Phase 4]
Phase 4 clinical trial evaluating the impact of neoadjuvant chemotherapy on cardiac function in perioperative breast cancer patients and exa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
A clinical trial evaluating whether digital breast tomosynthesis provides added value over standard mammography for local tumor staging in p…
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer [Phase 1]
This is a Phase 1 trial update for Bavarian Nordic's TAEK-VAC-HerBy Vaccine targeting brachyury and HER2-expressing cancers, including chord…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Clinical Exploratory Study on Predicting Drug Sensitivity for Breast Cancer Treatment Using Simulated Organoid Models.
A clinical exploratory study at Xiangya Hospital of Central South University is investigating predicting drug sensitivity in breast cancer u…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: AXillary Surgery After NeoAdjuvant Treatment
A clinical trial is evaluating axillary surgery strategies after neoadjuvant treatment in breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: MEthods for LOcalization of Different Types of Breast Lesions
A clinical trial is evaluating methods for localization of different types of breast lesions. It is currently recruiting and sponsored by th…
-
FDA approval · 2025-02-28FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ONTRUZANT (trastuzumab) by Organon LLC. This document confirms the supplemental approval for the…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology
A completed clinical trial evaluating how Oncotype DX reclassifies recurrence risk in breast cancer patients with uncertain tumor biology.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Seroma of the Mammary Gland [NA]
Clinical trial update for a study on seroma of the mammary gland in the context of breast cancer; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test [Phase 2]
A Phase 2 study evaluating functional RECAP-guided selection of advanced breast cancer patients for talazoparib treatment; the trial is curr…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer [Phase 2, Phase 3]
A completed Phase 2/3 trial update evaluating adjuvant dynamic marker-adjusted personalized therapy for risk assessment and therapy response…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer [Phase 2]
This is a Phase 2 adjuvant trial evaluating dynamic biomarker–adjusted personalized therapy to optimize risk assessment and therapy response…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer [Phase 3]
A Phase 3 trial comparing Abemaciclib (LY2835219) plus Fulvestrant versus Placebo plus Fulvestrant in previously treated breast cancer has p…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
This completed single-arm trial evaluated the feasibility and acceptability of a supportive intervention for Black and African American wome…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. [Phase 2]
This Phase 2 randomized open-label trial within the ADAPT protocol compares preoperative trastuzumab emtansine (T-DM1) with or without stand…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD
This is a clinical trial update describing a completed study evaluating functional and emotional quality of life aspects in breast cancer pa…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients [NA]
The document reports the completion of a clinical trial evaluating Meridian Yoga for chemotherapy-induced peripheral neuropathy in breast ca…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial at Baylor Breast Care Center is evaluating simvastatin in combination with dual anti-HER2 therapy for metastatic br…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China [NA]
A completed clinical trial from Fudan University evaluated a financial navigation program intended to reduce financial toxicity among women …
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating correlation between clinical response and pathologic response in patients with early breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response [Phase 3]
This Clinical Trials update describes a multicenter, open-label Phase 3 trial focused on optimizing taxane therapy in elderly patients with …